Neurosarcoidosis: Review and Update of the Mimic Disease
David Enrique Barbero Jiménez1*, Judit Villamor Rodríguez1, Maria de la Cruz Barbero Jiménez2 and Diego Domingo Merino3
1 Departament of Neurology, Hospital Universitario de Guadalajara, Guadalajara, Spain.
2 Departament of Oncology, Hospital General Universitario de Nuestra Señora del Prado, Talavera de la Reina, Spain.
3 Department of Hematology, Gregorio Marañón Hospital Research Foundation, Spain.
*Corresponding Author: David Enrique Barbero Jiménez, Departament of Neurology, Hospital Universitario de Guadalajara, Guadalajara, Spain.
DOI: https://doi.org/10.58624/SVOANE.2023.04.0101
Received: August 14, 2023 Published: August 28, 2023
Abstract
Sarcoidosis is a systemic inflammatory disorder characterized by non-caseating granulomas with variable involvement of the lungs, central nervous system (CNS), skin, liver, bone, and eye. Neurosarcoidosis is similarly heterogeneous with diverse anatomical manifestations and response to therapy. The diagnosis of neurosarcoidosis is established by the clinical syndrome, imaging and histopathological findings, and exclusion of other causes. In this narrative review, we summarize recent advances in the diagnosis and treatment of neurosarcoidosis.
Keywords: Sarcoidosis; Neurosarcoidosis; Cranial neuropathy; Myelopathy; CSF; Corticosteroids.
Citation: Jimenez DEB, Rodríguez JV, Jimenez MCB, Merino DD. Neurosarcoidosis: Review and Update of the Mimic Disease. SVOA Neurology 2023, 4:4, 108-114.
